Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: A new role for phospholipids in the regulation of cardiac calcium cycling?

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 2, 2009, Pages 559-566

  Hughes, Eleri ^a   Clayton, Jonathan C ^a   Middleton, David A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Isothermal titration calorimetry; Nuclear magnetic resonance; Phospholamban; Sarco(endo)plasmic calcium ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID DERIVATIVE; AMPHOLYTE; CALCIUM; CYTOPLASM PROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLAMBAN; PHOSPHOLIPID DERIVATIVE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ACETYLATION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; HEART MUSCLE CELL; HYDROLYSIS; ISOTHERMAL TITRATION CALORIMETRY; MEMBRANE VESICLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; RABBIT; SARCOPLASMIC RETICULUM; SOLID STATE;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALORIMETRY; CYTOPLASM; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIUM; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PROTEIN BINDING; RABBITS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; UNILAMELLAR LIPOSOMES;

EID: 59249086201     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.10.029     Document Type: Article

References (53)

1. Tada M., and Inui M. Regulation of calcium transport by the ATPase-phospholamban system. J. Mol. Cell. Cardiol. 15 (1983) 565-575
2. Kimura Y., Kurzydlowski K., Tada M., and MacLennan D.H. Phospholamban inhibitory function is activated by depolymerization. J. Biol. Chem. 272 (1997) 15061-15064
3. Autry J.M., and Jones L.R. Functional co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J. Biol. Chem. 272 (1997) 15872-15880
4. Asahi M., McKenna E., Kurzydlowski K., Tada M., and MacLennan D.H. Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP. J. Biol. Chem. 275 (2000) 15034-15038
5. Sasaki T., Inui M., Kimura Y., Kuzuya T., and Tada M. Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase. J. Biol. Chem. 267 (1992) 1674-1679
6. Cantilina T., Sagara Y., Inesi G., and Jones L.R. Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases - effect of a phospholamban antibody on enzyme activation by Ca2+. J. Biol. Chem. 268 (1993) 17018-17025
7. Hughes G., Starling A.P., Sharma R.P., East J.M., and Lee A.G. An investigation of the mechanism of inhibition of the Ca2+-ATPase by phospholamban. Biochem. J. 318 (1996) 973-979
8. Waggoner J.R., Huffman J., Froehlich J.P., and Mahaney J.E. Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate. Biochemistry 46 (2007) 1999-2009
9. Kimura Y., Kurzydlowski K., Tada M., and MacLennan D.H. Phospholamban regulates the Ca2+-ATPase through intramembrane interactions. J. Biol. Chem. 271 (1996) 21726-21731
10. Karim C.B., Marquardt C.G., Stamm J.D., Barany G., and Thomas D.D. Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase. Biochemistry 39 (2000) 10892-10897
11. Fujii J., Kadoma M., Tada M., Toda H., and Sakiyama F. Characterization of structural unit of phospholamban by amino-acid sequencing and electrophoretic analysis. Biochem. Biophys. Res. Commun. 138 (1986) 1044-1050
12. Toyofuku T., Kurzydlowski K., Tada M., and Maclennan D.H. Identification of regions in the Ca2+-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban. J. Biol. Chem. 268 (1993) 2809-2815
13. Toyofuku T., Kurzydlowski K., Tada M., and Maclennan D.H. Amino acids Glu(2) to Ile(18) in the cytoplasmic domain of phospholamban are essential for functional association with the Ca2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 269 (1994) 3088-3094
14. Toyofuku T., Tada M., and Maclennan D.H. Amino acids Lys-Asp-Asp-Lys400 in the cardiac Ca2+-ATPase (SERCA2) are critical for functional association with phospholamban. Biophys. J. 66 (1994) A121
15. Hughes G., East J.M., and Lee A.G. The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca2+-ATPase. Biochem. J. 303 (1994) 511-516
16. Sasaki T., Inui M., Kimura Y., Kuzuya T., and Tada M. Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic-reticulum - effects of synthetic phospholamban peptides on Ca2+ pump Atpase. J. Biol. Chem. 267 (1992) 1674-1679
17. Reddy L.G., Jones L.R., Cala S.E., Obrian J.J., Tatulian S.A., and Stokes D.L. Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca2+-Atpase. J. Biol. Chem. 270 (1995) 9390-9397
18. Jones L.R., and Field L.J. Residues 2-25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic-reticulum. J. Biol. Chem. 268 (1993) 11486-11488
19. Lockwood N.A., Tu R.S., Zhang Z.W., Tirrell M.V., Thomas D.D., and Karim C.B. Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban. Biopolymers 69 (2003) 283-292
20. Starling A.P., Sharma R.P., East J.M., and Lee A.G. The effect of N-terminal acetylation on Ca2+-ATPase inhibition by phospholamban. Biochem. Biophys. Res. Commun. 226 (1996) 352-355
21. Hughes E., Clayton J.C., Kitmitto A., Esmann M., and Middleton D.A. Solid-state NMR and functional measurements indicate that the conserved tyrosine residues of sarcolipin are involved directly in the inhibition of SERCA1. J. Biol. Chem. 282 (2007)
22. Zamoon J., Nitu F., Karim C., Thomas D.D., and Veglia G. Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4747-4752
23. Hughes E., and Middleton D.A. Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase. J. Biol. Chem. 278 (2003) 20835-20842
24. Kirby T.L., Karim C.B., and Thomas D.D. Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum Ca-ATPase. Biochemistry 43 (2004) 5842-5852
25. Clayton J.C., Hughes E., and Middleton D.A. The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces. Biochemistry 44 (2005) 17016-17026
26. Toyofuku T., Kurzydlowski K., Tada M., and MacLennan D. Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca2+-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban. J. Biol. Chem. 269 (1994) 22929-22932
27. East J.M., and Lee A.G. Lipid selectivity of the Ca2+ and Mg2+ ion dependent adenosinetriphosphate studied with fluorescence quenching by a bromine phospholipid. Biochemistry 21 (1982) 4144-4151
28. Waterborg J.H., and Matthews H.R. The Lowry method for protein quantitation. In: Walker J.M. (Ed). The Protein Protocols Handbook (1996), Humana press, New Jersey 7-9
29. Dalton K.A., Pilot J.D., Mall S., East J.M., and Lee A.G. Anionic phospholipids decrease the rate of slippage on the Ca2+-ATPase of sarcoplasmic reticulum. Biochem. J. 342 (1999) 431-438
30. Levy D., Gulik A., Bluzat A., and Rigaud J.L. Reconstitution of the sarcoplasmic-reticulum Ca2+-Atpase - mechanisms of membrane-protein insertion into liposomes during reconstitution procedures involving the use of detergents. Biochimica. Biophys. Acta 1107 (1992) 283-298
31. Hughes E., and Middleton D.A. Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase. J. Biol. Chem. 278 (2003) 20835-20842
32. Tatulian S.A., Chen B., Li J., Negash S., Middaugh C.R., Bigelow D.J., and Squier T.C. The inhibitory action of phospholamban involves stabilization of a-helices within the Ca-ATPase. Biochemistry 41 (2002) 741-751
33. Klodos I., Esmann M., and Post R.L. Large-scale preparation of sodium-potassium ATPase from kidney outer medulla. Kidney Int. 62 (2002) 2097-2100
34. Esmann M. ATPase and phosphatase activity of Na+, K+-ATPase: molar and specific activity, protein determination. Kidney Int. 156 (1988) 105-115
35. Davis J.H., Jeffrey K.R., Bloom M., Valic M.I., and Higgs T.P. Quadrupolar echo deuteron magnetic resonance spectroscopy in ordered hydrocarbon chains. Chem. Phys. Lett. 42 (1976) 390-394
36. Abraham T., Lewis R., Hodges R.S., and McElhaney R.N. Isothermal titration calorimetry studies of the binding of a rationally designed analogue of the antimicrobial peptide gramicidin S to phospholipid bilayer membranes. Biochemistry 44 (2005) 2103-2112
37. Oldenburg K.R., Epand R.F., Dorfani A., Vo K., Selick H., and Epand R.M. Conformational studies on analogs of recombinant parathyroid hormone and their interactions with phospholipids. J. Biol. Chem. 271 (1996) 17582-17591
38. Karim C.B., Paterlini M.G., Reddy L.G., Hunter G.W., Barany G., and Thomas D.D. Role of cysteine residues in structural stability and function of a transmembrane helix bundle. J. Biol. Chem. 276 (2001) 38814-38819
39. Kholodenko B.N., Hoek J.B., and Westerhoff H.V. Why cytoplasmic signalling proteins should be recruited to cell membranes. Trends Cell. Biol. 10 (2000) 173-178
40. Mascioni A., Karim C., Zamoon J., Thomas D.D., and Veglia G. Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban. J. Am. Chem. Soc. 124 (2002) 9392-9393
41. Karim C.B., Kirby T.L., Zhang Z.W., Nesmelov Y., and Thomas D.D. Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14437-14442
42. Andronesi O.C., Becker S., Seidel K., Heise H., Young H.S., and Baldus M. Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy. J. Am. Chem. Soc. 127 (2005) 12965-12974
43. Karim C.B., Zhang Z.W., Howard E.C., Torgersen K.D., and Thomas D.D. Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. J. Mol. Biol. 358 (2006) 1032-1040
44. Traaseth N.J., Thomas D.D., and Veglia G. Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca2+-ATPase complex. J. Mol. Biol. 358 (2006) 1041-1050
45. Toyoshima C., Asahi M., Sugita Y., Khanna R., Tsuda T., and MacLennan D.H. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 467-472
46. Pikula S., Epstein L., and Martonosi A. The relationship between phospholipid content and Ca2+-ATPase activity in the sarcoplasmic reticulum. Biochim. Biophys. Acta (BBA) - Biomembranes 1196 (1994) 1-13
47. Takagi A. Lipid composition of sarcoplasmic reticulum of human skeletal muscle. Biochim. Biophys. Acta (BBA) - Lipids Lipid. Metab. 248 (1971) 12-20
48. Gould G.W., McWhirter J.M., East J.M., and Lee A.G. Effects of diet on the function of sarcoplasmic-reticulum. Biochem. J. 245 (1987) 751-755
49. Dalton K.A., East J.M., Mall S., Oliver S., Starling A.P., and Lee A.G. Interaction of phosphatidic acid and phosphatidylserine with the Ca2+-ATPase of sarcoplasmic reticulum and the mechanism of inhibition. Biochem. J. 329 (1998) 637-646
50. Oxenoid K., and Chou J.J. The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10870-10875
51. Smith S.O., Kawakami T., Liu W., Ziliox M., and Aimoto S. Helical structure of phospholamban in membrane bilayers. J. Mol. Biol. 313 (2001) 1139-1148
52. Traaseth N.J., Verardi R., Torgersen K.D., Karim C.B., Thomas D.D., and Veglia G. Spectroscopic validation of the pentameric structure of phospholamban. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14676-14681
53. Asahi M., Nakayama H., Tada M., and Otsu K. Regulation of sarco(endo)plasmic reticulum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure. Trends Cardiovasc. Med. 13 (2003) 152-157